@AlexWTarr

Virologist at the University of Nottingham. Researching virus entry pathways and antiviral immunity

Joined February 2012
  • Tweets170
  • Following266
  • Followers274
4Media
Our study on the development of a simple low-cost pathway to accurately subtype #HepatitisC in sub-Saharan Africa has just been published in the Journal of Medical Virology. 👇🏽 @PostdocPat @JonathanKBall @AlexWTarr @UoNLifeSci @OneVirology onlinelibrary.wiley.com/doi/…

Hepatitis C subtyping assay failure in UK patients born in sub‐Saharan Africa: Implications for...

Background and Aims The newly developed direct-acting antivirals have revolutionized the treatment of chronic hepatitis C virus (HCV), with cure rates as high as 98% in some cohorts. Although...

onlinelibrary.wiley.com
1
4
15
Another preprint from our group! How to easily sub-type the incredibly diverse #HepatitisC #virus with genomes from Sub-Saharan Africa that most commercial assays fail upon. @PostdocPat @JonathanKBall @UoNLifeSci #HCV 👇🏽 medrxiv.org/content/10.1101/…

Hepatitis C subtyping assay failure in UK patients born in Sub-Saharan Africa: implications for...

The newly developed direct-acting antivirals (DAAs) have revolutionised the treatment of chronic hepatitis C virus (HCV), where cohort studies have shown that cure rates as high as 98% can be...

medrxiv.org
5
1
7
Replying to @nottmhospitals
@nottmhospitals and @UoNLifeSci researchers report rare bifacial weakness with paraesthesias variant of Guillain-Barré syndrome in four cases following ChAdOx1 SARS-CoV-2 vaccine. doi.org/10.1002/ana.26144 Vaccination remains extremely safe and the benefits far outweigh the risks.
3
6
Our Retrospective SARS-2 screening work is now published! Several missed cases, incl one of the first known community transmissions in the UK. Great collaborative effort with @JonathanKBall, @PostdocPat, @Theo_Tsoleridis, @mattloose, #NHS and many more! doi.org/10.1099/jgv.0.001595
1
11
1
12
Chuffed to have what might sadly be our final chapter on the #HCV p7 channel accepted at @eLife Huge team effort, many not on twitter, but thanks to those on here @OncoVirus_Leeds @ToshanaFoster @AbiBloy @HarrisLabLeeds @AlexWTarr @Stonehouse_Lab doi.org/10.7554/eLife.52555

Rationally derived inhibitors of hepatitis C virus (HCV) p7 channel activity reveal prospect for...

Exploiting virus-encoded ion channels as drug targets drove a multi-faceted approach to deriving potent small molecules targeting HCV p7, simultaneously providing new insights into its fundamental...

elifesciences.org
9
9
46
New paper published in Journal of Clinical Virology 'Nanopore sequencing from extraction-free direct PCR of dried serum spots for portable hepatitis B virus drug-resistance typing' bit.ly/2YAGgaC @stuartastbury @AlexWTarr
3
1
7
A project we started back in 2016, before extraction-free amplification was all the rage! 'Nanopore sequencing from extraction-free direct PCR of dried serum spots for portable hepatitis B virus drug-resistance typing' sciencedirect.com/science/ar…
1
2
8
Latest research just published by the @UoNLifeSci @UoNresearch virology group on human bocavirus infections.
Patrick McClure@PostdocPat29 May 2020
Pleased to get this study on human #bocavirus published recently with @ViroGem and @AlexWTarr; plenty of it about and severe in a few instances unfortunately: sciencedirect.com/science/ar…
4
5
A small milestone reached in #Covid_19 @UoNresearch today - 600th #Nottingham sample prepared for antibody testing by @AlexWTarr and #PaddyTighe at @UoNLifeSci virology labs.
1
8
1
39
Health officials say a third UK case of #coronavirus has been confirmed in a patient who caught it in an Asian country other than China. The person's being treated in a specialist unit. Jonathan Ball is Professor of emerging viruses at The University of #Nottingham:
1
Barney King from @OneVirology @UniNottinghamIC telling us about 'hard to pseudotype' viruses with #HepatitisC as as a model. Even clones within same patient behave differently!
2
6
Will irving gets basl award for being totally fabulous #BASL
6
5
25
Extraordinary dishonesty: papers claiming computational design of anti-flu and anti-Zika antibodies just tweaked existing antibodies. And why did @cellhostmicrobe @PNASNews publish papers on designed antibodies that didn't even give "designed" sequences? tandfonline.com/doi/full/10.…

Connecting the sequence dots: shedding light on the genesis of antibodies reported to be designed...

Two recent publications out of the same research laboratory report on structure-based in silico design of antibodies against viral targets without sequence disclosure. Cross-referencing the publish...

tandfonline.com
2
27
1
54
We have a website! nottingham.ac.uk/onevirology
1
7
1
7
Alex Tarr retweeted
KreyLab@KreyLab10 May 2019
Postdoc-position available!
11
6
our new website is finally live nottingham.ac.uk/research/gr…
1
1
Rein in the four horsemen of irreproducibility nature.com/articles/d41586-0…
2
1
We're looking for a postdoc to join the lab! Use structural computational biology to decode and design immune recognition. View the posting and apply here: ejobs.umd.edu/postings/68728
3
1
We have positive news on #HepB on children under 5 born w #HBV declining from 1.3% in 2015 to 0.8% in 2017. However, for the 257 mln living w/ chronic infection, testing, treatment access remains extremely low. #ILC2019.
1
31
4
42
Replying to @OneVirology
@OneVirology student members in action at #microsoc19 today: Joe Chappell and Chun Goddard in the virology workshops this afternoon!
1
1
Load more